Phosphate supplementation prevents a decrease of triiodothyronine and increases resting metabolic rate during low energy diet

Journal of Physiology and Pharmacology

Volumn 47, Issue 2, 1996, Pages 373-383

  Nazar, K ^a,c   Kaciuba Uscilko H ^a   Szczepanik, J ^a   Zemba, A W ^a   Kruk, B ^a   Chwalbinska Moneta J ^a   Titow Stupnicka, E ^a   Bicz, B ^a   Krotkiewski, M ^b  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c POLISH ACADEMY OF SCIENCES   (Poland)

Author keywords

hormones; phosphates; resting metabolic rate; thyroid; weight reduction

Indexed keywords

CALCIUM PHOSPHATE; CATECHOLAMINE; GLUCOSE; GROWTH HORMONE; HYDROCORTISONE; INSULIN; LIOTHYRONINE; LIPID; MINERAL; PHOSPHATE; PLACEBO; POTASSIUM DIHYDROGEN PHOSPHATE; REDUSAN COMBI; REDUSAN FIBRE; REDUSAN MINERAL; SODIUM DIHYDROGEN PHOSPHATE; TESTOSTERONE; THYROXINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CALORIC INTAKE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; DIETARY FIBER; FEMALE; HUMAN; METABOLIC RATE; OBESITY; ORAL DRUG ADMINISTRATION; PHARMACEUTICS; PREVENTION; SINGLE BLIND PROCEDURE; TABLET; THYROID HORMONE BLOOD LEVEL; WEIGHT REDUCTION;

ADULT; BODY WEIGHT; DIET, REDUCING; DOUBLE-BLIND METHOD; ENERGY INTAKE; ENERGY METABOLISM; FEMALE; HUMANS; MIDDLE AGED; OBESITY; OXYGEN CONSUMPTION; PHOSPHATES; TRIIODOTHYRONINE;

EID: 0029900668     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Apfelbaum M, Bostsarrou J, Lacatis D. Effect of caloric restriction and excessive caloric intake on energy expenditure. Am J Clin Nutr 1971; 24: 405-409.
2. Warnold J, Carlgen G, Krotkiewski M. Energy expenditure and body composition during weight reduction in hyperplastic obese women. Am J Clin Nutr 1983; 38: 680-693.
3. Barrows K, Snook JT. Effect of high protein, neru low calorie diet on resting metabolism, thyroid hormones, and energy expenditure of obese middle-aged women. Am J Clin Nutr 1987; 45: 391-398.
4. Ravussin E, Burnand B, Schutz V, Jequier E. Twenty-four hour energy expenditure and resting metabolic rate in obese, moderately obese and control subjects. Am J Clin Nutr 1982; 35: 566-573.
5. Velle SL. Amatrude M, Forbes GB, Lockwood DA. Resting metabolic rates of obese women after rapid weight loss. J Clin Endocrinol Metab 1984; 59: 41-44.
6. Krotkiewski M, Tross L, Bjorntorp P, Holm G The effect of very-low calorie diet with and without chronic exercise on thyroid and sex hormones, plasma proteins, oxygen uptake, insulin and C-peptide concentrations in obese women. Int J Obesity 1981; 5: 281-293.
7. 4 supplement. In The 1st European Congress of Obesity. Abstract Book. Stockholm, 1988, p. 202.
8. 4 treated obese women. In The 1st European Congress of Obesity. Abstract Book. Stockholm, 1988, p. 214.
9. Jaedig S, Henningsen NC. Increased metabolic rate in obese women after ingestion of potassium, magnesium and phosphate-enriched orange juice or injection of ephedrine. Int J Obesity 1990; 14: 429-436.
10. Lindgarde F, Tress E. Serum inorganic phosphate in middle aged men: An inverse relation to body weight. Acta Med Scand 1977; 202: 307-311.
11. Keller V, Berger W. Prevention of hypophosphatemia by phosphate infusion during treatment of diabetic ketoacidosis and hyperonkotic coma. Diabetes 1980; 29: 87-95.
12. DeFronzo RA, Lang R. Hypophosphatemia and glucose intolerance: Evidence for tissue insensitivity to insulin. N Engl J Med 1980; 303: 1259-1263.
13. Shimazu S, Inoue Y, Tani Y, Yamada H. Entzymatic micro-determination of serum free fatty acids. Analyt Biochem 1979; 98: 341-345.
14. DaPrada M, Zurcher G. Radioenzymatic assay of plasma and urinary catecholamine in men and various animal species: Physiological and pharmacological applications. In Radioimmunoassay of Drugs and Hormones in Cardiovascular Medicine, Albertini, Da Prada, and Pescar (eds.). Amsterdam, Elsevier North Holland, 1979, pp. 112-119.
15. Durnin JVGA, Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness measurements of 481 men and women aged from 16 to 72 years. Br J Nutr 1974; 32: 77-97.
16. Benesch R, Benesch RE. Intracellular organic phosphates as regulators of oxygen release by haemoglobin. Nature 1969; 221: 618.
17. Code R, Coute M, Zauner Ch. Effects of phosphate loading on 2, 3 diphosphoglycerate and maximal oxygen uptake. Med Sci Sports Exerc 1984; 16: 263-266.
18. Kreider RP, Miller GW, Melvin H. Effect of phosphate loading on oxygen uptake, ventilatory, anaerobic threshold and performance. Med Sci Sporta Exerc 1990; 22: 250-256.
19. Briedle DL, Stager JM, Brechne NF, Farber MO. Phosphate supplementation, cardiovascular function, and exercise performance in humans. J Appl Physiol 1988; 65: 1821-1826.
20. Bark H, Nizri M, Tarsiuk A, Heimer D. Effects of hyperphosphatemia on diaphragmatic strenght and endurance. J Appl Physiol 1992; 73: 82-87.
21. Tsuboi KK, Fukunaga K. Inorganic phosphate and enhanced glucose degradation by the intact erythrocyte. J Biol Chem 1965; 240: 2806-2810.
22. Rose JA, Warms JVB, O'Connell L. Role of inorganic phosphate in stumulating the glucose utilization of human red blood cells. Bioch Biophys Res Comm 1964; 15: 33-37.
23. Chastiotis D. The regulation of glycogen phosphorylase and glycogen break-down in human skeletal muscle. Acta Physiol Scand 1983; suppl. 18.
24. Danforth E Jr, Burger Ag. The impact of nutrition on thyroid hormone physiology and action. Ann Rev Nutr 1989; 9: 201-227.
25. 3 syndrome in exercising women. Am J Physiol 1993; 264: R924-R930.
26. 3 in mononuclear blood cells in obese women. Metabolism 1989; 38: 555-561.
27. Fagerberg B, Andersson OK, Isaksson B, Bjorntorp P. Blood pressure control during weight reduction in obese hypertensive men: separate effects of sodium and energy restriction. Br Med J 1984; 288: 1-14.
28. Sowers JR, Nyby M, Stern N et al. Blood pressure and hormone changes associated with weight reduction ion the obese. Hypertension 1982; 4: 686-691.
29. Scherrer U, Nussberger J, Torriani S et al. Effect of weight reduction of moderately overweight patients on recorded ambulatory blood pressure and free cytosolic platelet calcium. Circulation 1991; 83: 552-558.
30. Anderssson B, Wallin G, Hedner T, Ahlberg A-Ch, Andersson O. Acute effects of short-term fasting on blood pressure, circulating noradrenaline and efferent sympathetic nerve activity. Int J Obesity 1989; 13 (Suppl. 1): 50-92.
31. Weinsier RL, James LD, Darnell BE, Dustan HP, Birch R, Hunter GR. Obesity related hypertension: evaluation of the separate effects of energy restriction and weight reduction on hemodynamic and neuroendocrine status. Am J Med 1991; 90: 460-468.
32. Krotkiewski M, Butruk E, Lembrowska L. L'influence d'un regime hypocalorique a 44% de lipides et de l'amalgrissement sur l'excretion urinaire des corticosteroids chez les obeses. Le Diabete 1966; 14: 253-256.
33. Zelissen PN, Koppeschaar HP, Erkelens DW, Thijssen JH. Beta-endorphin and adrenocortical function in obesity. Clin Endocrinol 1991; 35: 369-372.